139 Assessing the inclusion of women and minority populations in ClinicalTrials.gov results in studies focused on type 2 diabetes and GLP1 drugs
Reynolds J, Barone C, Calvocoressi L. 139 Assessing the inclusion of women and minority populations in ClinicalTrials.gov results in studies focused on type 2 diabetes and GLP1 drugs. Journal Of Clinical And Translational Science 2025, 9: 41-41. PMCID: PMC12050505, DOI: 10.1017/cts.2024.799.Peer-Reviewed Original ResearchType 2 diabetesBlack/African AmericanClinical Trials Transformation InitiativeAfrican American individualsCount of participantsGLP-1Diversity of participantsHispanic ethnicityStudy characteristicsIntervention studiesMinority populationsDiverse populationsAmerican individualsOddsStatistically significant differenceEthnicityMedical advancesGroup comparisonsParticipantsInclusion of womenInfluence of covariatesBaseline countsClinical researchMean ratiosClinical trials
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply